Combination expands breadth of commercialization and compliance services
Two New Jersey-based companies, both with expertise in life sciences commercial services, will now be known only as QPharma. Qforma, until now owned by a private investment firm, BelHealth Investment Partners, has developed analytics technology for “understanding and penetration” of professional relationship networks among healthcare providers and their affiliations, as well as a launch planning tool, iLaunch.
For 21 years, QPharma has provided a range of IT-based services, including systems validation, sample distribution management, state and federal transparency reporting and salesforce training. More recently, it has moved into key opinion-leader (KOL) identification, influence mapping and analytics.
“The purchase of Qforma is a natural progression of the incremental growth strategy that has served QPharma well in the past two decades,” said QPharma president and CEO, Patrick Den Boer, in a statement. “The outstanding technology platform and solution base they have built is a perfect complement to QPharma’s suite of business intelligence tools.”
Purchase price was not disclosed. QPharma says that its national headcount will get a 10% bump-up, but didn't release a total employment figure.
almost 11 years ago
Managing logistics partnerships in uncertain timesalmost 11 years ago
Vaccines manufacturers wrestle with public health policyalmost 11 years ago
The impact of the anti-vaccination lobbyalmost 11 years ago
Logistics providers confront a complex, global healthcare marketalmost 11 years ago
Digitized stress analysis improves blister performancealmost 11 years ago
Enterprise solutions for cold chain managementalmost 11 years ago
Pharma logistics--so what?almost 11 years ago
Industry hit a record low number of FDA OPDP actions in 2015
